Gara Jalqabaatti › Saree Oljoo › Minnesota

Qorannoo klinikaalii Saree Oljoo Minnesota keessatti

Qorannoo 68 Saree Oljoo f Minnesota keessatti hirmaatuu jiru.

Magaalota Minnesota keessatti

Takkalaa qorannoo (Ingiliffa)

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jira

Umuriin 18 fi ol · Dubartoota · Haaromfame 05-Onk-2026 · NCT06058650

The Vanguard Study: Testing a New Way to Screen for Cancer

Minneapolis VA Medical Center, Minneapolis

Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo

Umuriin 45 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06995898

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Minnesota Oncology Hematology, P.A., Minneapolis

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Minnesota Oncology Hematology P A, Minneapolis
Allina Hlth Cancer Inst Minneapolis, Minneapolis

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
fi 48 dabalataa

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06172478

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo

Umuriin 18 hanga 45 · Dubartoota · Haaromfame 01-Onk-2026 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Minnesota, Masonic Cancer Center, Minneapolis
Mayo Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06369285

PRE-ISPY Phase I/II Oncology Platform Program

University of Minnesota Masonic Cancer Center, Minneapolis
Mayo Clinic Comprehensive Cancer Center, Rochester

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05868226

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Saint Paul

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Mayo Clinic Cancer Center, Rochester
HealthPartners Frauenshuh Cancer Center, Saint Louis Park

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07007559

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Mayo Clinic, Rochester

Namoota walitti qabaa jira

Umuriin 30 fi ol · Dubartoota · Haaromfame 25-Ful-2026 · NCT02945579

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Mayo Clinic, Rochester

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07214532

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Minneapolis

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07085767

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Mayo Clinic - Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Mayo Clinic in Rochester, Minnesota, Rochester
Metro-Minnesota Community Clinical Oncology, Saint Louis Park

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Mayo Clinic in Rochester, Minnesota, Rochester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Dubartoota · Haaromfame 22-Ful-2026 · NCT07287098

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Mayo Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Healthpartners Regions Specialty Clinics, Saint Louis Park
Healthpartners Regions Specialty Clinics, Saint Paul

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Mayo Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07109726

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Mayo Clinic Health System - Albert Lea, Albert Lea
Mayo Clinic - Mankato, Mankato
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
fi 2 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06492616

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Metro-Minnesota Community Oncology Research Consortium, Saint Paul

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT03424005

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Mayo Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05307705

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Avera Cancer Institute - Marshall, Marshall

Namoota walitti qabaa jiraSadarkaa 2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT07405801

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Mayo Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05315700

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07287917

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

University of Minnesota Medical Center, Minneapolis

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06790693

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06072612

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

University of Minnesota Masonic Cancer Center, Minneapolis

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07216105

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

Mayo Clinic, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06488378

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Riverwood Healthcare Center, Aitkin
Essentia Health - Baxter Clinic, Baxter
Sanford Joe Lueken Cancer Center, Bemidji
fi 47 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 60 · Dubartoota · Haaromfame 02-Ful-2026 · NCT05879926

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo

Umuriin 18 hanga 100 · Dubartoota · Haaromfame 27-Hag-2026 · NCT07207564

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06500481

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jira

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07047872

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Minnesota Oncology Hematology, Maple Grove
Local Institution - 0372, Minneapolis

Namoota walitti qabaa jiraSadarkaa 2/3

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06926868

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Minnesota Oncology, Maple Grove

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health Cancer Center, Duluth
Mayo Clinic Health Systems-Mankato, Mankato
fi 1 dabalataa

Namoota walitti qabaa jiraSadarkaa 3

Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06748222

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Minnesota Oncology Hematology, Maplewood

Namoota walitti qabaa jiraSadarkaa 1/2

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Mayo Clinic in Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT04521764

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Mayo Clinic Rochester, Rochester

Namoota walitti qabaa jiraSadarkaa 1

Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06562192

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.